Sharon J. Herring, MD, MPH, Associate Professor of Medicine at the Lewis Katz School of Medicine at Temple University, provided perspective for an I.M. Matters from ACP article on glucagon-like peptide-1 (GLP-1) receptor agonists and alternative agents for weight loss.
Important announcement concerning Temple Health and Keystone First. Our provider agreement with Keystone First is scheduled to end on July 31st. Click the link below to learn about your options for continuing care at Temple Health.
Learn More
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH